Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder

被引:14
作者
Chang, Chuan-Chia
Shiah, I-Shin
Yeh, Chin-Bin
Wang, Tzong-Shi
Chang, Hsin-An
机构
[1] Tri Serv Gen Hosp, Dept Psychiat, Taipei 114, Taiwan
[2] Natl Def Med Ctr, Taipei, Taiwan
关键词
anticonvulsants; bipolar disorder; hypersensitivity syndrome; lamotrigine;
D O I
10.1016/j.pnpbp.2005.11.033
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Anticonvulsant hypersensitivity syndrome (AHS) is a rare but life-threatening adverse effect of aromatic anticonvulsants such as phenytoin, phenobarbital and carbamazepine, although there is extensive experience with AHS related to these anticonvulsants. Very few cases of lamotrigine-associated AHS have been reported in bipolar patients and most reported cases were published in non-psychiatric journals. The authors describe here the occurrence of an AHS in a 48-year-old bipolar woman who was treated with lamotrigine, valproic acid and venlafaxine for her depressive symptoms. She developed a high fever, generalized maculopapular rash, pancytopenia, pneumonitis and hepatitis after we added lamotrigine to valproate and venlafaxine. These adverse drug reactions resolved after the discontinuation of lamotrigine and valproate, and the administration of oral antihistamine and corticosteroid. Our case demonstrates that the most important steps in the management of lamotrigine-associated AHS are to recognize the disorder, discontinue the offending anticonvulsants, provide supportive care in an inpatient setting, and treat with antihistamine and steroids when appropriate. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:741 / 744
页数:4
相关论文
共 15 条
[1]  
Beller TC, 2002, ALLERGY ASTHMA PROC, V23, P415
[2]   A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder [J].
Bowden, CL ;
Calabrese, JR ;
Sachs, G ;
Yatham, LN ;
Asghar, SA ;
Hompland, M ;
Montgomery, P ;
Earl, N ;
Smoot, TM ;
DeVeaugh-Geiss, J .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (04) :392-400
[3]   A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder [J].
Calabrese, JR ;
Bowden, CL ;
Sachs, G ;
Yatham, LN ;
Behnke, K ;
Mehtonen, OP ;
Montgomery, P ;
Ascher, J ;
Paska, W ;
Earl, N ;
DeVeaugh-Geiss, J .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (09) :1013-1024
[4]   A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression [J].
Calabrese, JR ;
Bowden, CL ;
Sachs, GS ;
Ascher, JA ;
Monaghan, E ;
Rudd, GD .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) :79-+
[5]   Rash in multicenter trials of lamotrigine in mood disorders: Clinical relevance and management [J].
Calabrese, JR ;
Sullivan, JR ;
Bowden, CL ;
Suppes, T ;
Goldberg, JF ;
Sachs, GS ;
Shelton, MD ;
Goodwin, FK ;
Frye, MA ;
Kusumakar, V .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) :1012-1019
[6]   Adding lamotrigine to valproate: Incidence of rash and other adverse effects [J].
Faught, E ;
Morris, G ;
Jacobson, M ;
French, J ;
Harden, C ;
Montouris, G ;
Rosenfeld, W .
EPILEPSIA, 1999, 40 (08) :1135-1140
[7]  
Fervenza FC, 2000, AM J KIDNEY DIS, V36, P1034
[8]   Lamotrigine-associated rash: Risk benefit considerations in adults and children [J].
Guberman, AH ;
Besag, FMC ;
Brodie, MJ ;
Dooley, JM ;
Duchowny, MS ;
Pellock, JM ;
Richens, A ;
Stern, RS ;
Trevathan, E .
EPILEPSIA, 1999, 40 (07) :985-991
[9]  
Huang Chin-Wei, 2002, Kaohsiung Journal of Medical Sciences, V18, P566
[10]   Anticonvulsant hypersensitivity syndrome - Incidence, prevention and management [J].
Knowles, SR ;
Shapiro, LE ;
Shear, NH .
DRUG SAFETY, 1999, 21 (06) :489-501